CClinicalTrials.gg
CompletedNCT04026672Updated Feb 10, 2020

Hemp Oil + User Experience Study

An observational study in General Wellbeing, Gastrointestinal Health and Physical Discomfort, sponsored by Thorne HealthTech, Inc. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-10.

Sponsored by Thorne HealthTech, Inc · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
201
Ages
18 Years and older
Sex
All
01

Study summary

Presented as an online survey, this study seeks to better understand how Thorne customers are using and experiencing the new Hemp Oil + product and how they feel it compares in the marketplace. Hemp Oil + is a combination product with a proprietary blend of hemp, clove, black pepper, hops, and rosemary extracts. People who have independently elected to purchase and use Hemp Oil + before the study starts will be invited to voluntarily participate. If they meet study requirements and give consent they will answer questions online about their experience with Hemp Oil +. Questions address general demographics and wellness, general impressions of the product, how it compares to other products, and any effect it has had on their gastrointestinal health, physical discomfort, sleep, and mood. The survey is expected to take 15-30 min of participant time. Data will be analyzed to determine whether the customer experience with Hemp Oil + is as favorable as it seems from anecdotal reports. Analysis will also be conducted to find patterns that can inform future studies, marketing, and customer education efforts.

02

Conditions studied

  • General Wellbeing
  • Gastrointestinal Health
  • Physical Discomfort
  • Sleep
  • Mood
03

In context

Lead sponsor

Thorne HealthTech, Inc is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

People who have purchased Hemp Oil +

Inclusion criteria

  • Has personally used at least one bottle (30 gelcaps) of Hemp Oil +
  • Provides consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Cannot access or use the electronic survey for any reason
  • Was pregnant or nursing when taking Hemp Oil +
  • Is a Thorne employee not willing to participate without compensation
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
201 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Assess impact to overall quality of life (QoL) after taking Hemp Oil +

    Questionnaire gathering data from the past 30 or more days

    Time frame: 1 Day

Secondary outcomes

  1. Assess impact to specific QoL factors - GI health, mood, sleep, physical discomfort - after taking Hemp Oil +

    Questionnaire gathering data from the past 30 or more days

    Time frame: 1 Day

  2. Gain insight into user perspective on product quality, efficacy, and rationale for continuing/discontinuing use

    Questionnaire gathering data from the past 30 or more days

    Time frame: 1 Day

07

Study locations

1 site
  • Online Survey for Thorne Research, Inc.
    Summerville, South Carolina 29486, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 10, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04026672
Lead sponsor
Thorne HealthTech, Inc
Responsible party
Sponsor
First posted
Jul 19, 2019
Start date
Jan 22, 2020
Primary completion
Feb 4, 2020
Completion
Feb 4, 2020
Last update
Feb 10, 2020

Study contacts

Jacqueline Jacques, ND
principal investigator · Thorne Research
Sheena Smith, MS
principal investigator · Thorne Research

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion